The biotechnology market in Germany is expected to grow at a CAGR of 10.70% from 2024 to 2032. Key drivers of this growth include advancements in genomics and molecular biology, a growing demand for personalized medicine, the increasing prevalence of chronic diseases, government support and funding, and innovations in biopharmaceuticals and agricultural biotechnology. https://www.imarcgroup.com/germany-biotechnology-market